Anbalcabtagene Autoleucel
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Anbalcabtagene Autoleucel, covering 2025-12-17 to 2025-12-17. Get the full timeline:
Most recent: Clinical Trial Update: Anbalcabtagene Autoleucel in Relapsed/Refractory CNS Lymphoma [Phase 2]